These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9589299)

  • 21. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Harbord M; Annese V; Vavricka SR; Allez M; Barreiro-de Acosta M; Boberg KM; Burisch J; De Vos M; De Vries AM; Dick AD; Juillerat P; Karlsen TH; Koutroubakis I; Lakatos PL; Orchard T; Papay P; Raine T; Reinshagen M; Thaci D; Tilg H; Carbonnel F;
    J Crohns Colitis; 2016 Mar; 10(3):239-54. PubMed ID: 26614685
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extra-intestinal manifestations].
    Descos L
    Rev Prat; 1991 Feb; 41(5):415-8. PubMed ID: 2011689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous manifestations in inflammatory bowel disease: a single institutional study of non-neoplastic biopsies over 13 years.
    Ko JS; Uberti G; Napekoski K; Patil DT; Billings SD
    J Cutan Pathol; 2016 Nov; 43(11):946-955. PubMed ID: 27494987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis].
    Richter L; Rappersberger K
    Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic manifestations associated with chronic inflammatory bowel diseases].
    Bouhnik Y; Benamouzig R; Rybojad M; Matuchansky C; Rambaud JC
    Gastroenterol Clin Biol; 1993; 17(2):121-9. PubMed ID: 8500699
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extraintestinal complications of inflammatory bowel disease].
    Nagasaka M; Fujita H; Kamano T; Komura N; Hirata I
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():406-10. PubMed ID: 23126127
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
    Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
    Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the cutaneous manifestations of HIV infection. Clinical and pathologic features.
    Aftergut K; Cockerell CJ
    Dermatol Clin; 1999 Jul; 17(3):445-71, vii. PubMed ID: 10410852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.
    Marzano AV; Borghi A; Meroni PL; Crosti C; Cugno M
    Autoimmunity; 2014 May; 47(3):146-53. PubMed ID: 24437626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extraintestinal manifestations in chronic inflammatory bowel diseases].
    Rath HC; Herfarth HH
    Versicherungsmedizin; 2002 Mar; 54(1):16-20. PubMed ID: 11933861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: skin complications associated with inflammatory bowel disease.
    Tavarela Veloso F
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel diseases: Part II. Extraintestinal involvement and management.
    Gitnick G
    Am Fam Physician; 1989 Feb; 39(2):225-33. PubMed ID: 2644791
    [No Abstract]   [Full Text] [Related]  

  • 36. [Extraintestinal manifestations in inflammatory bowel disease].
    Larsen S; Bendtzen K; Nielsen OH
    Ugeskr Laeger; 2009 Oct; 171(43):3078-83. PubMed ID: 19852894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous manifestations of end-stage renal disease.
    Robinson-Bostom L; DiGiovanna JJ
    J Am Acad Dermatol; 2000 Dec; 43(6):975-86;quiz 987-90. PubMed ID: 11100013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous vasculitis and inflammatory bowel diseases.
    Simonetti O; Postacchini V; Offidani A
    G Ital Dermatol Venereol; 2015 Apr; 150(2):233-6. PubMed ID: 25830412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possible role of mucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases].
    Müzes G
    Orv Hetil; 2003 Jul; 144(29):1441-6. PubMed ID: 12939865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Extraintestinal manifestations of chronic inflammatory intestinal disease].
    Berges Magaña MA; Castillo Grau P; Patrón Costas G; Rodríguez Blanes JA; Muñoz Núñez F; Presa Valle M; González Murillo M; Suárez de Parga JM
    Rev Clin Esp; 1992 Nov; 191(8):435-40. PubMed ID: 1488518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.